- Filed
- Mar 12, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 11, 2026 | 13.67M sh |
| Shares Diluted | FY 2025 · Dec 31, 2025 | 13.52M sh |
| Shares Diluted | FY 2025 · Dec 31, 2024 | 3.45M sh |
| Capex | FY 2025 · Dec 31, 2025 | $46K |
| Capex | FY 2025 · Dec 31, 2024 | $52K |
| Operating Cash Flow | FY 2025 · Dec 31, 2025 | −$51.83M |
| Operating Cash Flow | FY 2025 · Dec 31, 2024 | −$51.12M |
| Cash And Equivalents | FY 2025 · Dec 31, 2025 | $59.05M |
| Cash And Equivalents | FY 2025 · Dec 31, 2024 | $110.76M |
| Stockholders Equity | FY 2025 · Dec 31, 2025 | $56.18M |
| Stockholders Equity | FY 2025 · Dec 31, 2024 | $103.83M |
| Stockholders Equity restated | FY 2025 · Dec 31, 2023 | −$101.84M |
| Current Liabilities | FY 2025 · Dec 31, 2025 | $5.92M |
| Current Liabilities | FY 2025 · Dec 31, 2024 | $10.53M |
| Total Liabilities | FY 2025 · Dec 31, 2025 | $5.93M |
| Total Liabilities | FY 2025 · Dec 31, 2024 | $11.08M |
| Current Assets | FY 2025 · Dec 31, 2025 | $60.84M |
| Current Assets | FY 2025 · Dec 31, 2024 | $113M |
| Total Assets | FY 2025 · Dec 31, 2025 | $62.12M |
| Total Assets | FY 2025 · Dec 31, 2024 | $114.91M |
| Eps Diluted | FY 2025 · Dec 31, 2025 | −$4.40 |
| Eps Diluted | FY 2025 · Dec 31, 2024 | −$15.28 |
| Eps Basic | FY 2025 · Dec 31, 2025 | −$4.40 |
| Eps Basic | FY 2025 · Dec 31, 2024 | −$15.28 |
| Sga Expense | FY 2025 · Dec 31, 2025 | $14.69M |
| Sga Expense | FY 2025 · Dec 31, 2024 | $10.59M |
| Rd Expense | FY 2025 · Dec 31, 2025 | $48.26M |
| Rd Expense | FY 2025 · Dec 31, 2024 | $43.8M |
| Net Income | FY 2025 · Dec 31, 2025 | −$59.52M |
| Net Income | FY 2025 · Dec 31, 2024 | −$52.67M |
| Operating Income | FY 2025 · Dec 31, 2025 | −$62.95M |
| Operating Income | FY 2025 · Dec 31, 2024 | −$54.39M |